Latest Posts


Mar 24

Partex NV announces collaboration with Althea DRF Lifesciences to provide comprehensive end-to-end services to accelerate drug discovery and development

Frankfurt, Germany; 28 March 2024 – Partex Group, a pioneer in AI-driven drug discovery, announces a collaboration with Althea DRF...
Read More


Mar 24

Innovative AI technology in oncology: Partex Group presents results from a pilot project

During the German Cancer Congress 2024 in Berlin, the companies Innoplexus AG /Amrit AG, companies of Partex N.V., presented the...
Read More

Innoplexus wins Horizon Interactive Gold Award for Curia App

Read More

Can AI help in Drug Development ?

This is the talk given by Innoplexus Co-founder & CTO, Mr. Gaurav Tripathi at DataHack 2018 – an event by Analytics Vidhya.

Lot of analytics companies from silicon valley to budding startups are targeting to solve the problem of drug discovery to suggesting prescriptions. But would you really trust a cancer medicine suggested by a software program?

AI today is at a level of doing lower cognitive tasks such as aggregating numbers, finding patterns, suggesting correlations rather than understanding human level intelligence of thoughts, implications or emotions. That is why it should be used to solve the time-consuming and mundane problems leaving the quick and theoretically complex decisions to the judgement of the experts such as doctors, making it win-win for everyone.

Here, Gaurav would talk about three AI technologies Innoplexus has developed to cut down drug development time at all stages and how should one pursue the field to facilitate traditional institutions for patient care.

Evolutionary learning based Incremental crawling

Computer vision based information comprehension

Ontology-based life sciences language processing

This video originally published on youtube channel of Analytics Vidhya.

Featured News

Strategic partnership announcement: Innoplexus holding company Partex NV is pleased to announce a one-of-its-kind collaboration with Anavex Life science corp. for Artificial Intelligence (AI) enabled drug development and healthcare sales marketing

Strategic partnership announcement: Innoplexus holding company Partex NV is pleased

Exciting News! Anavex Life Sciences and Partex NV Announce Strategic Partnership to Enhance Patient Experience. Anavex Life Sciences Corp. and Partex NV N.V. Group are pleased to announce…